IRCT20130603013566N13Not yet recruitingPhase 3
Investigating the results of adding growth hormone to the ovulation stimulation regimen in IVF-ICSI cycles in patients with diminished ovarian reserve
Vice chancellor for Research,Tabriz University Of Medical Sciences0 sites96 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 96
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to 42 years (—)
- Sex
- Female
Inclusion Criteria
- •Age less than or equal to 42 years
- •Absence of internal uterine anomalies such as adenomyosis and uterine fibroids and uterine abnormalities and adenomyosis
- •No systemic diseases
- •Consent to study
- •BMI below 30 kg/m2
- •The number of antral follicles below 5 on the 3rd to 5th days of the menstrual cycle per ovary
- •AMH less than or equal to 1 ng/ml
Exclusion Criteria
- •The recipient of the donor eggs
- •Use of surrogacy
- •Severe impairment of sperm parameters
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)EUCTR2004-004835-72-GBniversity of Birmingham200
Completed
Not Applicable
Growth hormone deficiency and clottingISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
Not yet recruiting
Not Applicable
Growth hormone with anatagonist in low respondersPACTR201306000461792Prof Dr Hassa Aly Hassan Elmaghraby200
Completed
Not Applicable
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
Active, not recruiting
Not Applicable
Effects of growth hormone treatment to patients with partial growth hormone deficiency, with special emphasis on acute phase proteins and pro-inflammatory cytokines.EUCTR2005-004478-26-SEKarolinska universitetssjukhuset